Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Leonard Oppenheimer"'
Autor:
Torsten Westermeier, Juergen Weber, Leonard Oppenheimer, Kenneth Todd Moore, Christopher C. Nessel, Andrea Nadel, Xiang Sun, Sanjay Jalota, Nancy Cook-Bruns, Gary Peters, Paul Burton, Guohua Pan, Frank Misselwitz, Elisabeth Perzborn, Peter M DiBattiste, Troy C. Sarich, Lloyd Haskell, Scott D. Berkowitz, Anthonie W. A. Lensing, Dagmar Kubitza
Publikováno v:
Annals of the New York Academy of Sciences. 1291:42-55
The development of rivaroxaban (XARELTO®) is an important new medical advance in the field of oral anticoagulation. Thrombosis-mediated conditions constitute a major burden for patients, healthcare systems, and society. For more than 60 years, the p
Autor:
Michael Lee, Hong Tian, Roderick J. A. Little, Alexei N. Plotnikov, Janet Wittes, Leonard Oppenheimer, Eun Young Suh, Troy C. Sarich, C. Michael Gibson, Surya Mohanty, Xiang Sun, Paul Burton, Nancy Cook-Bruns, Julia Wang
Publikováno v:
Clinical trials (London, England). 13(3)
Background: The potential impact of missing data on the results of clinical trials has received heightened attention recently. A National Research Council study provides recommendations for limiting missing data in clinical trial design and conduct,
Autor:
Steven M. Snapinn, Leonard Oppenheimer, Valerii V. Fedorov, Chi-Hse Teng, Ivan S.F. Chan, Tom Uryniak, John Zhang, Qi Jiang
Publikováno v:
Statistics in Biopharmaceutical Research. 3:476-487
Ideally, a clinical trial should be able to demonstrate not only a statistically significant improvement in the primary efficacy endpoint, but also that the magnitude of the effect is clinically relevant. One approach to address this question, often
Autor:
Leonard Oppenheimer, Mei Cheng, Rachel Weinstein, Alexei N. Plotnikov, Robert Zolynas, George Griffin, Paul Burton, Zhong Yuan, John Zhang, Mary S. Lee
Publikováno v:
Pharmacoepidemiology and Drug Safety. 19:911-920
SUMMARY Purpose Heart failure is a significant public health problem. The present study is intended to explore in a research database whether antithrombotic therapies (ATTs) affect cardiovascular outcomes in patients with incident heart failure (IHF)
Autor:
Troy C, Sarich, Gary, Peters, Scott D, Berkowitz, Frank, Misselwitz, Christopher C, Nessel, Paul, Burton, Nancy, Cook-Bruns, Anthonie W A, Lensing, Lloyd, Haskell, Elisabeth, Perzborn, Dagmar, Kubitza, Kenneth T, Moore, Sanjay, Jalota, Juergen, Weber, Guohua, Pan, Xiang, Sun, Torsten, Westermeier, Andrea, Nadel, Leonard, Oppenheimer, Peter M, DiBattiste
Publikováno v:
Annals of the New York Academy of Sciences. 1291
The development of rivaroxaban (XARELTO®) is an important new medical advance in the field of oral anticoagulation. Thrombosis-mediated conditions constitute a major burden for patients, healthcare systems, and society. For more than 60 years, the p
Autor:
Zhong, Yuan, Rachel, Weinstein, John, Zhang, Mei, Cheng, George, Griffin, Robert, Zolynas, Alexei N, Plotnikov, Mary S, Lee, Leonard, Oppenheimer, Paul, Burton
Publikováno v:
Pharmacoepidemiology and drug safety. 19(9)
Heart failure is a significant public health problem. The present study is intended to explore in a research database whether antithrombotic therapies (ATTs) affect cardiovascular outcomes in patients with incident heart failure (IHF).Using the Unite
Autor:
Uma Kher, Leonard Oppenheimer
Publikováno v:
Statistics in medicine. 18(16)
Investigators often report results of studies comparing the proportions of subjects who have clinically meaningful responses to various therapeutic regimens. When the outcome variable is a continuous measure this involves dichotomizing the observed r
Autor:
C. Conrad Johnston, Ego Seeman, Steven T. Harris, David B. Karpf, Desmond E. Thompson, Arthur C. Santora, Laurence J. Hirsch, Silvano Adami, Leonard Oppenheimer, Kristine E. Ensrud, Deborah R. Shapiro
Publikováno v:
Maturitas. 27:294-295
Objective. —To evaluate the effect of treatment with alendronate sodium, a potent aminobisphosphonate, on the incidence of nonvertebral fractures in postmenopausal women with osteoporosis. Data Sources. —Published data and data on file at Merck R
Autor:
Leonard Oppenheimer
Publikováno v:
Statistical Methods in Medical Research. 6:187-188
Publikováno v:
Controlled Clinical Trials. 16:93S-94S